Journal of the American Geriatrics Society· 2023Q1
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults
- 1,356citations
- Q1SCImago
- 2023year
Short summary
The 2023 update to the AGS Beers Criteria® provides an expert-reviewed list of medications best avoided by older adults, incorporating new evidence and usability enhancements.
AI-generated from the title and abstract; the full text is not read.
Key points
- The AGS Beers Criteria® is updated regularly to reflect new evidence on medication safety in older adults.
- The 2023 update includes new criteria, modified existing ones, and improved formatting for usability.
- The criteria are designed for adults 65+ in most care settings, excluding hospice and end-of-life.
- Application requires thoughtful clinical decision-making, not rigid adherence.
AI-generated from the title and abstract; the full text is not read.
Abstract
The American Geriatrics Society (AGS) Beers Criteria® (AGS Beers Criteria®) for Potentially Inappropriate Medication (PIM) Use in Older Adults is widely used by clinicians, educators, researchers, healthcare administrators, and regulators. Since 2011, the AGS has been the steward of the criteria and has produced updates on a regular cycle. The AGS Beers Criteria® is an explicit list of PIMs that are typically best avoided by older adults in most circumstances or under specific situations, such as in certain diseases or conditions. For the 2023 update, an interprofessional expert panel reviewed the evidence published since the last update (2019) and based on a structured assessment process approved a number of important changes including the addition of new criteria, modification of existing criteria, and formatting changes to enhance usability. The criteria are intended to be applied to adults 65 years old and older in all ambulatory, acute, and institutionalized settings of care, except hospice and end-of-life care settings. Although the AGS Beers Criteria® may be used internationally, it is specifically designed for use in the United States and there may be additional considerations for certain drugs in specific countries. Whenever and wherever used, the AGS Beers Criteria® should be applied thoughtfully and in a manner that supports, rather than replaces, shared clinical decision-making.
The authors' abstract, as published at the source. Journal of the American Geriatrics Society, 2023 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Geriatrics and Gerontology
Geriatrics and GerontologyMedicine